Triggering of β1-integrin chain induces platelet adhesion to cultured endothelium

Aldo Del Maschio, Inés Martín-Padura, Sergio Bernasconi, Elisabetta Dejana

Research output: Contribution to journalArticle

Abstract

We report here that platelets adhere to cultured endothelial cells (EC) on exposure to the integrin β1 activating monoclonal antibody (mAb) BV7. The effect of BV7 is exerted mostly on platelets rather than EC. BV7 does not induce platelet aggregation or 5-hydroxytryptamine (5-HT) release and does not increase platelet adhesion to matrix proteins. Another activating β1 mAb, Lia1/2, triggers an effect similar to BV7. Blocking antibodies to α2 and β1, but not to other integrin chains, are able to inhibit BV7-mediated adhesion. Moreover, the effect of BV7 requires active cellular metabolism and is not inhibited by platelet treatment with aspirin, by the PAF receptor antagonist BN50730, the phosphokinase C inhibitor staurosporin, or by the cAMP or cGMP enhancers prostaglandin E1 and sodium nitroprusside, respectively. Finally, BV7-mediated adhesion was enhanced by the endoperoxide analogue U46619. These data describe a novel mechanism of platelet adhesion to endothelial cells. This adhesion pathway appears to be mediated by α2β1- integrin on platelets and a still-undefined endothelial counter receptor.

Original languageEnglish
Pages (from-to)2663-2671
Number of pages9
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume17
Issue number11
Publication statusPublished - 1997

Fingerprint

Integrins
Endothelium
Blood Platelets
Endothelial Cells
Monoclonal Antibodies
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Blocking Antibodies
Alprostadil
Nitroprusside
Platelet Aggregation
Aspirin
Cultured Cells
Serotonin
Phosphotransferases
Proteins

Keywords

  • Adhesion
  • Endothelial cells
  • Integrins
  • Platelets

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Del Maschio, A., Martín-Padura, I., Bernasconi, S., & Dejana, E. (1997). Triggering of β1-integrin chain induces platelet adhesion to cultured endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology, 17(11), 2663-2671.

Triggering of β1-integrin chain induces platelet adhesion to cultured endothelium. / Del Maschio, Aldo; Martín-Padura, Inés; Bernasconi, Sergio; Dejana, Elisabetta.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 17, No. 11, 1997, p. 2663-2671.

Research output: Contribution to journalArticle

Del Maschio, A, Martín-Padura, I, Bernasconi, S & Dejana, E 1997, 'Triggering of β1-integrin chain induces platelet adhesion to cultured endothelium', Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 11, pp. 2663-2671.
Del Maschio, Aldo ; Martín-Padura, Inés ; Bernasconi, Sergio ; Dejana, Elisabetta. / Triggering of β1-integrin chain induces platelet adhesion to cultured endothelium. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 1997 ; Vol. 17, No. 11. pp. 2663-2671.
@article{030ed3fe5ed24dfb891ee15f9bfab623,
title = "Triggering of β1-integrin chain induces platelet adhesion to cultured endothelium",
abstract = "We report here that platelets adhere to cultured endothelial cells (EC) on exposure to the integrin β1 activating monoclonal antibody (mAb) BV7. The effect of BV7 is exerted mostly on platelets rather than EC. BV7 does not induce platelet aggregation or 5-hydroxytryptamine (5-HT) release and does not increase platelet adhesion to matrix proteins. Another activating β1 mAb, Lia1/2, triggers an effect similar to BV7. Blocking antibodies to α2 and β1, but not to other integrin chains, are able to inhibit BV7-mediated adhesion. Moreover, the effect of BV7 requires active cellular metabolism and is not inhibited by platelet treatment with aspirin, by the PAF receptor antagonist BN50730, the phosphokinase C inhibitor staurosporin, or by the cAMP or cGMP enhancers prostaglandin E1 and sodium nitroprusside, respectively. Finally, BV7-mediated adhesion was enhanced by the endoperoxide analogue U46619. These data describe a novel mechanism of platelet adhesion to endothelial cells. This adhesion pathway appears to be mediated by α2β1- integrin on platelets and a still-undefined endothelial counter receptor.",
keywords = "Adhesion, Endothelial cells, Integrins, Platelets",
author = "{Del Maschio}, Aldo and In{\'e}s Mart{\'i}n-Padura and Sergio Bernasconi and Elisabetta Dejana",
year = "1997",
language = "English",
volume = "17",
pages = "2663--2671",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Triggering of β1-integrin chain induces platelet adhesion to cultured endothelium

AU - Del Maschio, Aldo

AU - Martín-Padura, Inés

AU - Bernasconi, Sergio

AU - Dejana, Elisabetta

PY - 1997

Y1 - 1997

N2 - We report here that platelets adhere to cultured endothelial cells (EC) on exposure to the integrin β1 activating monoclonal antibody (mAb) BV7. The effect of BV7 is exerted mostly on platelets rather than EC. BV7 does not induce platelet aggregation or 5-hydroxytryptamine (5-HT) release and does not increase platelet adhesion to matrix proteins. Another activating β1 mAb, Lia1/2, triggers an effect similar to BV7. Blocking antibodies to α2 and β1, but not to other integrin chains, are able to inhibit BV7-mediated adhesion. Moreover, the effect of BV7 requires active cellular metabolism and is not inhibited by platelet treatment with aspirin, by the PAF receptor antagonist BN50730, the phosphokinase C inhibitor staurosporin, or by the cAMP or cGMP enhancers prostaglandin E1 and sodium nitroprusside, respectively. Finally, BV7-mediated adhesion was enhanced by the endoperoxide analogue U46619. These data describe a novel mechanism of platelet adhesion to endothelial cells. This adhesion pathway appears to be mediated by α2β1- integrin on platelets and a still-undefined endothelial counter receptor.

AB - We report here that platelets adhere to cultured endothelial cells (EC) on exposure to the integrin β1 activating monoclonal antibody (mAb) BV7. The effect of BV7 is exerted mostly on platelets rather than EC. BV7 does not induce platelet aggregation or 5-hydroxytryptamine (5-HT) release and does not increase platelet adhesion to matrix proteins. Another activating β1 mAb, Lia1/2, triggers an effect similar to BV7. Blocking antibodies to α2 and β1, but not to other integrin chains, are able to inhibit BV7-mediated adhesion. Moreover, the effect of BV7 requires active cellular metabolism and is not inhibited by platelet treatment with aspirin, by the PAF receptor antagonist BN50730, the phosphokinase C inhibitor staurosporin, or by the cAMP or cGMP enhancers prostaglandin E1 and sodium nitroprusside, respectively. Finally, BV7-mediated adhesion was enhanced by the endoperoxide analogue U46619. These data describe a novel mechanism of platelet adhesion to endothelial cells. This adhesion pathway appears to be mediated by α2β1- integrin on platelets and a still-undefined endothelial counter receptor.

KW - Adhesion

KW - Endothelial cells

KW - Integrins

KW - Platelets

UR - http://www.scopus.com/inward/record.url?scp=0031456028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031456028&partnerID=8YFLogxK

M3 - Article

C2 - 9409240

AN - SCOPUS:0031456028

VL - 17

SP - 2663

EP - 2671

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 11

ER -